Two Sigma Investments’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Other funds holding ADMA
Two Sigma Investments's ADMA Position: Q3 2026 in Review
Two Sigma Investments reduced its ADMA Biologics (ADMA) stake by 0.57% in Q3 2026, selling an estimated $107K and leaving 2,008,321 shares worth $20.1M. The position accounts for 0.01% of the portfolio, ranked #1012.
Two Sigma Investments first reported a position in ADMA in Q2 2019 and has held it in 20 quarters since. The position peaked at $71.8M in Q3 2024. 329 funds tracked by Wall St. Rank hold ADMA as of Q3 2026.
- Two Sigma Investments held 2,008,321 shares of ADMA Biologics worth $20.1M as of Q3 2026.
- Two Sigma Investments sold 11,566 ADMA Biologics shares in Q3 2026, an estimated $107K.
- ADMA Biologics made up 0.01% of Two Sigma Investments's portfolio in Q3 2026, its #1012 holding.
- Two Sigma Investments first reported a position in ADMA Biologics in Q2 2019 and has held it in 20 quarters since.
- Two Sigma Investments's ADMA Biologics position peaked at $71.8M in Q3 2024.
- 329 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2026.
Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.